Company Filing History:
2 out of 504 
1 out of 7 Years Active: 2012-2018
Title: Adam J Friedman: Innovator in Nanoparticle Delivery Systems
Introduction
Adam J Friedman is a notable inventor based in New York, NY (US). He has made significant contributions to the field of nanoparticle delivery systems, holding 2 patents that focus on innovative methods for drug delivery and treatment of various disorders. His work is characterized by a commitment to advancing medical technology through the use of nanoparticles.
Latest Patents
Friedman's latest patents include a "Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof." This invention involves nanoparticles that contain S-nitrosothiol (SNO) groups, which are covalently bonded to the nanoparticles or encapsulated within them. The patent outlines methods for preparing these nanoparticles, which include a series of steps involving a buffer solution and specific chemical compounds.
Another significant patent is for "Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof." This invention provides a matrix that encapsulates nitric oxide, allowing for its release when exposed to an aqueous environment. The methods described in this patent aim to treat infections and disorders effectively.
Career Highlights
Adam J Friedman has worked with prestigious institutions such as the Albert Einstein College of Medicine and the La Jolla Bioengineering Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Friedman has collaborated with notable colleagues, including Joel M Friedman and Parimala Nacharaju. These partnerships have further enriched his research and development efforts in nanoparticle technology.
Conclusion
Adam J Friedman is a pioneering inventor whose work in nanoparticle delivery systems has the potential to revolutionize medical treatments. His patents reflect a deep understanding of the complexities of drug delivery and the innovative approaches necessary to address current medical challenges.